SCHEMBL15539286

SCHEMBL15539286

CCNC(=O)C(=Cc1ccccc1)N(CC)CC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.48
MTNR1B P49286 2/20 0.48
L3MBTL1 Q9Y468 3/20 0.47
NPC1 O15118 2/20 0.47
ALDH1A1 P00352 4/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
RECQL P46063 1/20 0.41
MME P08473 2/20 0.40
LMNA P02545 5/20 0.40
MAPT P10636 3/20 0.40
HTT P42858 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
AKR1C3 P42330 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4729447 0.82 NPC1 (0.54) MTNR1AMTNR1BL3MBTL1NPC1ALDH1A1
SCHEMBL11142380 0.82 NPC1 (0.54) MTNR1AMTNR1BL3MBTL1NPC1ALDH1A1
SCHEMBL3951056 0.80 NPC1 (0.53) MTNR1AMTNR1BL3MBTL1NPC1ALDH1A1
SCHEMBL6265387 0.78 NPC1 (0.50) MTNR1AMTNR1BL3MBTL1NPC1ALDH1A1
SCHEMBL974306 0.77 RAB9A (0.67) MTNR1AMTNR1BNPC1ALDH1A1RAB9A
SCHEMBL974305 0.77 RAB9A (0.67) MTNR1AMTNR1BNPC1ALDH1A1RAB9A
SCHEMBL13123964 0.76 MME (0.54) MTNR1AMTNR1BL3MBTL1NPC1ALDH1A1
SCHEMBL6974614 0.73 LMNA (0.52) MTNR1AMTNR1BL3MBTL1NPC1ALDH1A1
SCHEMBL13123603 0.73 MTNR1A (0.45) MTNR1AMTNR1BL3MBTL1NPC1ALDH1A1
SCHEMBL6630042 0.71 AKR1C3 (0.50) MTNR1AMTNR1BL3MBTL1NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2844642-A1 COMPOUNDS FOR INHIBITING CELL PROLIFERATION IN EGFR-DRIVEN CANCERS ARIAD PHARMACEUTICALS, INC. (US) 2015-03-11 EP disclosed
WO-2013169401-A1 COMPOUNDS FOR INHIBITING CELL PROLIFERATION IN EGFR-DRIVEN CANCERS ARIAD PHARMACEUTICALS, INC. (US) 2013-11-14 WO disclosed